Supernus Pharma (SUPN) Tops Q2 EPS by 14c, Revenues Miss; Offers FY18 Revenue Outlook Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. ADYYF
10. DVLT

Go back to Supernus Pharma (SUPN) Tops Q2 EPS by 14c, Revenues Miss; Offers FY18 Revenue Outlook Below Consensus
SUPERNUS PHARM (NASDAQ: SUPN) Delayed: 48.27 +1.12 (2.38%)
Previous Close $47.15    52 Week High $26.84 
Open $46.70    52 Week Low $9.51 
Day High $48.39    P/E N/A 
Day Low $46.57    EPS $-2.62 
Volume 331,731